Ruxandra Gref

Ruxandra Gref is a Researcher at the Molecular Science Institute of Orsay (ISMO - Université Paris-Saclay, CNRS), focusing on nanomedicines for infections and cancer. Her work bridges chemistry, physics, and biology to develop innovative drug delivery systems.

• Education: Master of Science at Université Paris-Sud; graduated from École nationale supérieure des industries chimiques (ENSIC) in Nancy, specializing in process engineering.

Her research targets antibiotic-resistant bacteria and cancer through supramolecular assemblies like cyclodextrin networks. She coordinated the European-funded Cyclon Hit project, which produced 80 publications, 3 patents, and multiple workshops. She advocates for interdisciplinary collaboration and societal impact of basic research, leveraging the Saclay region's concentration of labs and expertise.

• Awards:
  • Seqens 2020 Prize (French Academy of Sciences)
  • CNRS Silver Medal (2019)
  • Stars of Europe Jury Special Prize (2018)

In her career, she transitioned to biomedical research after a postdoctoral stint at MIT, where she explored polymer-based drug reservoirs. Her current projects continue to push boundaries in therapeutic delivery systems within European consortia.